{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:40:26Z","timestamp":1784684426214,"version":"3.55.0"},"reference-count":73,"publisher":"American Chemical Society (ACS)","issue":"11","funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA041730"],"award-info":[{"award-number":["R01 DA041730"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hennepin Healthcare Research Institute"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2018,11,5]]},"DOI":"10.1021\/acs.molpharmaceut.8b00592","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T22:38:58Z","timestamp":1537569538000},"page":"4947-4962","source":"Crossref","is-referenced-by-count":57,"title":["Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins"],"prefix":"10.1021","volume":"15","author":[{"given":"Federico","family":"Baruffaldi","sequence":"first","affiliation":[{"name":"Hennepin Healthcare Research Institute (HHRI, formerly Minneapolis Medical Research Foundation or MMRF), 701 Park Avenue, Minneapolis, Minnesota 55415, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9665-2921","authenticated-orcid":true,"given":"April Huseby","family":"Kelcher","sequence":"additional","affiliation":[{"name":"Hennepin Healthcare Research Institute (HHRI, formerly Minneapolis Medical Research Foundation or MMRF), 701 Park Avenue, Minneapolis, Minnesota 55415, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Laudenbach","sequence":"additional","affiliation":[{"name":"Hennepin Healthcare Research Institute (HHRI, formerly Minneapolis Medical Research Foundation or MMRF), 701 Park Avenue, Minneapolis, Minnesota 55415, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Gradinati","sequence":"additional","affiliation":[{"name":"Hennepin Healthcare Research Institute (HHRI, formerly Minneapolis Medical Research Foundation or MMRF), 701 Park Avenue, Minneapolis, Minnesota 55415, United States"},{"name":"Dipartimento di Chimica e Tecnologie Farmaceutiche, Socrates Program, Universit\u00e1 degli Studi di Milano, Milan 20122, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajinkya","family":"Limkar","sequence":"additional","affiliation":[{"name":"University of Minnesota, Minneapolis, Minnesota 55455, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Roslawski","sequence":"additional","affiliation":[{"name":"University of Minnesota, Minneapolis, Minnesota 55455, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Birnbaum","sequence":"additional","affiliation":[{"name":"University of Minnesota, Minneapolis, Minnesota 55455, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lees","sequence":"additional","affiliation":[{"name":"Fina Biosolutions, LLC, Rockville, Maryland 20850, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Hassler","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, North Carolina 27709-2194, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Runyon","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, North Carolina 27709-2194, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1036-0184","authenticated-orcid":true,"given":"Marco","family":"Pravetoni","sequence":"additional","affiliation":[{"name":"Hennepin Healthcare Research Institute (HHRI, formerly Minneapolis Medical Research Foundation or MMRF), 701 Park Avenue, Minneapolis, Minnesota 55415, United States"},{"name":"Departments of Medicine and Pharmacology, Center for Immunology, University of Minnesota, Minneapolis, Minnesota 55455, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2018,9,21]]},"reference":[{"key":"ref1\/cit1","unstructured":"World Drug Report 2018. https:\/\/www.unodc.org\/wdr2018\/index.html."},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkx083"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2017.1303141"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.24095\/hpcdp.38.6.01"},{"key":"ref5\/cit5","volume-title":"Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52)","year":"2017"},{"key":"ref6\/cit6","unstructured":"Drugs Involved in U.S. Overdose Deaths, 2000\u20132016. https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates (accessed February 01, 2018)."},{"key":"ref7\/cit7","unstructured":"Rhyan, C. The Potential Societal Benefit Of Eliminating The Opioid Crisis Exceeds $95 Billion Per Year; Research Brief for Altarum, November 16, 2017."},{"key":"ref8\/cit8","unstructured":"CDC.  Wide-ranging OnLine Data for Epidemiologic\nResearch (WONDER);Center for Disease Control\nand Prevention Department of Health & Human Services, 2012."},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1706626"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.2174\/187152711799219316"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201511654"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1219159110"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyu093"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1021\/jm3013745"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.201194"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101807"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115696"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.5b00085"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1021\/mp400631w"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.101"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096547"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2014.01.010"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184876"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.7b03334"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01427"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.317"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.128"},{"key":"ref28\/cit28","first-page":"3005","volume-title":"Human Vaccines & Immunotherapeutics","volume":"12","author":"Pravetoni M.","year":"2016"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-420118-7.00014-7"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2015.07.002"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.3923\/jpt.2009.30.35"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.20882\/adicciones.101"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1124\/pr.117.013904"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076557"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500385"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.09.015"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2018.03.002"},{"issue":"4","key":"ref38\/cit38","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/iai.58.4.1004-1009.1990","volume":"58","author":"Halpern J. L.","year":"1990","journal-title":"Infect. Immun."},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.189506"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.11.004"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23777-6"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.4161\/hv.26109"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1002\/immu.200310003"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.7.2502"},{"key":"ref45\/cit45","volume-title":"Guidance for industry: Q6B specifications: test procedures and acceptance criteria for biotechnological \/biological products","year":"1999"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2008.10.080"},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines5020011"},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.06.026"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.7b00933"},{"key":"ref50\/cit50","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-014-8035-x"},{"key":"ref51\/cit51","doi-asserted-by":"publisher","DOI":"10.1021\/bc500016k"},{"key":"ref52\/cit52","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.6b00977"},{"key":"ref53\/cit53","doi-asserted-by":"publisher","DOI":"10.1078\/0171-9335-00363"},{"key":"ref54\/cit54","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.720"},{"key":"ref55\/cit55","doi-asserted-by":"publisher","DOI":"10.1021\/jm2004943"},{"key":"ref56\/cit56","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01427"},{"key":"ref57\/cit57","doi-asserted-by":"publisher","DOI":"10.1002\/jms.3224"},{"key":"ref58\/cit58","unstructured":"Stellar\nBiotechnologies, I. KLH Site, Keyhole Limpet Hemocyanin\nKnowledge Base. http:\/\/www.klhsite.org\/klh-clinical-trials\/ (accessed February, 27, 2018)."},{"key":"ref59\/cit59","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.6b00682"},{"key":"ref60\/cit60","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.04.027"},{"key":"ref61\/cit61","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.5b00345"},{"key":"ref62\/cit62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002547"},{"key":"ref63\/cit63","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.280"},{"key":"ref64\/cit64","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2016.09.008"},{"key":"ref65\/cit65","doi-asserted-by":"publisher","DOI":"10.4161\/hv.26635"},{"key":"ref66\/cit66","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-4328(99)00036-0"},{"key":"ref67\/cit67","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.117.247049"},{"key":"ref68\/cit68","doi-asserted-by":"publisher","DOI":"10.1021\/bc034158v"},{"key":"ref69\/cit69","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines5020011"},{"key":"ref70\/cit70","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2015.09.012"},{"key":"ref71\/cit71","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2015.02.030"},{"issue":"1","key":"ref73\/cit73","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0021-9258(17)32814-4","volume":"252","author":"Helting T. B.","year":"1977","journal-title":"J. Biol. Chem."},{"key":"ref74\/cit74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.11.004"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.8b00592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T09:23:55Z","timestamp":1682501035000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.8b00592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,21]]},"references-count":73,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11,5]]}},"alternative-id":["10.1021\/acs.molpharmaceut.8b00592"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00592","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,21]]}}}